RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases

PURPOSE: RAS mutations have been reported to be a potential prognostic factor in patients with colorectal liver metastases (CLM). However, the impact of RAS mutations on response to chemotherapy remains unclear. We sought to determine the association between RAS mutations and response to preoperativ...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Surg Oncol
Prif Awduron: Zimmitti, Giuseppe, Shindoh, Junichi, Mise, Yoshihiro, Kopetz, Scott, Loyer, Evelyne M., Andreou, Andreas, Cooper, Amanda B., Kaur, Harmeet, Aloia, Thomas A., Maru, Dipen M., Vauthey, Jean-Nicolas
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318708/
https://ncbi.nlm.nih.gov/pubmed/25227306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4042-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg